IL6 and lung cancer: In addition, a study found that during anti-CTLA4 and anti-PD-1 combination immunotherapy, a lung cancer patient developed cytokine release syndrome due to a new crown vaccination, elevated cytokine levels (IL-6, IL-10, and IFN-γ), and grade 2 liver and kidney dysfunction (93).